刺激性激活树突细胞向纳米疫苗,唤起强大的抗原交叉呈现,用于癌症免疫疗法
Nguyen Thi Nguyen1, Xuan Thien Le1, Woo Tak Lee1
1School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of Korea.
Bioactive materials
|September 18, 2024
概括
这项研究开发了一种新型纳米疫苗 (Si9GM),有效向树突细胞,以增强抗原呈现和强大的抗瘤免疫力. 该纳米疫苗通过促进T细胞反应和与现有治疗方法协同作用,对癌症免疫治疗具有前景.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 基于纳米疫苗的免疫疗法对长期免疫有希望,但在瘤抗原呈现方面面临挑战.
- 1型常规树突细胞 (cDC1s) 对于抗原与CD8+T细胞的交叉呈现至关重要.
研究的目的:
- 开发一种选择性向cDC1s的纳米疫苗,以获得有效的抗原交叉呈现和强大的抗瘤免疫力.
- 研究纳米疫苗激活STING通路并增强抗瘤免疫反应的能力.
主要方法:
- 一种新型纳米疫苗 (Si9GM) 使用骨髓树突细胞衍生膜,cDC1特异性抗体,瘤和纳米颗粒上的STING激动剂进行了设计.
- 该纳米疫苗的设计是针对cDC1s,并促进溶酶体逃脱,以实现高效的抗原交叉呈现.
主要成果:
- Si9GM疫苗成功向cDC1s,导致强大的抗原交叉呈现和干扰素I型激活.
- 接种疫苗导致细胞毒性T细胞增加,调控性T细胞 (Tregs) 减少,以及M1/M2巨分化.
- 这种纳米疫苗与αPD-1免疫检查点封锁具有协同效应.
结论:
- 开发的纳米疫苗作为人工抗原呈现细胞,直接激活T细胞并促进DC成熟.
- Si9GM对临床癌症治疗和精准医学应用具有重大潜力.
更多相关视频
相关概念视频
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Vaccinations
44.1K
Overview
44.1K


